Neuroinflammation and complexes of 17β-hydroxysteroid dehydrogenase type 10 - amyloid β in alzheimeŕs disease

Current Alzheimer Research

Volumn 10, Issue 2, 2013, Pages 165-173

  Krištofiková, Zdenatofiková ^a   Řípová, Daniela ^a   Bartoš, Aleš ^a,b   Bocková, Markéta ^c   Hegnerová, Kateřina ^c   Říčný, Jan ^a   Čechová, Linda ^b   Vrajová, Monika ^a   Homola, Jiří ^c  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c INSTITUTE OF PHOTONICS AND ELECTRONICS   (Czech Republic)

Author keywords

Alzheimer's disease; Amyloid ; Mitochondrial enzyme; Neuroinflammation

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; HYDROXYSTEROID DEHYDROGENASE;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOIMMUNE DISEASE; BIOSENSOR; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENZYME BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; MALE; NERVE DEGENERATION; NERVOUS SYSTEM INFLAMMATION; PRIORITY JOURNAL; SURFACE PLASMON RESONANCE;

17-HYDROXYSTEROID DEHYDROGENASES; AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CENTRAL NERVOUS SYSTEM DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFLAMMATION; MALE; PEPTIDE FRAGMENTS; PERIPHERAL NERVOUS SYSTEM DISEASES; STATISTICS, NONPARAMETRIC; SURFACE PLASMON RESONANCE; VASCULAR DISEASES;

EID: 84874953574     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/1567205011310020006     Document Type: Article

References (24)

1. Wirths O, Multhaup G, Bayer TA. A modified -amyloid hypothesis: intraneuronal accumulation of the -amyloid peptide the first step of a fatal cascade. J Neurochem 91: 513-520 (2004).
2. Parihar MS, Brewer GJ. Mitoenergetic failure in Alzheimer disease. Am J Physiol Cell Physiol 292: 8-23 (2007).
3. Swerdlow RH, Burns JM, Khan SM. The Alzheimeŕs mitochondrial cascade hypothesis. J Alzheimers Dis 20: 265-279 (2010).
4. Chen JX, Yan SS. Role of mitochondrial amyloidin Alzheimeŕs disease. J Alzheimers Dis 20: 569-578 (2010).
5. Lovell MA, Xiong S, Markesbery WR, Lynn BC. Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide. Neurochem Res 30: 113-122 (2005).
6. Oppermann UCT, Salim S, Tjernberg LO, Terenius L, Jörnvall H. Binding of amyloid -peptide to mitochondrial hydroxyacyl-CoA dehydrogenase (ERAB): regulation of an SDR enzyme activity with implications for apoptosis in Alzheimeŕs disease. FEBS Lett 451: 238-242 (1999).
7. He XY, Wen GY, Merz G, Lin D, Yang YZ, Mehta P, et al. Abundant type 10 17 -hydroxysteroid dehydrogenase in the hippocampus of mouse Alzheimeŕs disease model. Mol Brain Res 99: 46-53 (2002).
8. Yan SD, Stern DM. Mitochondrial dysfunction and Alzheimeŕs disease: role of amyloidpeptide alcohol dehydrogenase (ABAD). Int J Exp Pathol 86: 161-171 (2005).
9. Hovorková P, Krištofiková Z, Hořínek A, Řípová D, Majer E, Zach P, et al. Lateralization of 17beta-hydroxysteroid dehydrogenase type 10 in hippocampi of demented and psychotic people. Dement Geriatr Cogn Disord 26: 193-198 (2008).
10. Krištofiková Z, Bocková M, Hegnerová K, Bartoš A, Klaschka J,Říčn J, et al. Enhanced levels of mitochondrial enzyme 17 -hydroxysteroid dehydrogenase type 10 in patients with Alzheimer disease and multiple sclerosis. Mol Biosyst 5: 1174-1179 (2009).
11. Dutta R, McDonough J, Yin X, Peterson J, Chang A, Torres T, et al. Mitochondrial dysfunction as a cause of axonal degeneration in multiple sclerosis patients. Ann Neurol 59: 478-489 (2006).
12. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EI. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 34: 1021-1029 (2009).
13. Wood PL. Microglia: Roles of microglia in chronic neurodegenerative diseases. In (Ed: Wood PL). Neuroinflammation: Mechanisms and Management. Second edition. Totowa, New Jersey: Humana Press pp. 3-27 (2003).
14. Sastre M, Richardson JC, Gentleman SM, Brooks DJ. Inflammatory risc factors and pathologies associated with Alzheimeŕs disease. Curr Alzheimer Res 8: 132-141 (2011).
15. Johnstone M, Gearing AJ, Miller KM. A central role for astrocytes in the inflamatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced. J Neuroimmunol 93: 182-193 (1999).
16. Di Filippo M, Chiasserini D, Tozzi A, Picconi B, Calabresi P. Mitochondria and the link between neuroinflammation and neurodegeneration. J Alzheimers Dis 20: 369-379 (2010).
17. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225 (2011). Neuroinflammation and Complexes of 17ß-Hydroxysteroid
18. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimeŕs disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimeŕs Disease. Neurology 34: 939-944 (1984).
19. Homola J, Dostálek J, Chen S, Rasooly A, Jiang S, Yee SS. Spectral surface plasmon resonance biosensor for detection of staphylococcal enterotoxin B in milk. Int J Food Microbiol 75: 61-69 (2002).
20. Wiltfang J, Lewczuk P, Riederer P, Grüblatt E, Hock C, Scheltens P, et al. Consensus paper of the WFSBP task force on biological markers of dementia: the role of CSF and blood analysis in the early and differential diagnosis of dementia. World J Biol Psychiatry 65: 69-84 (2005).
21. Gehrmann J, Banati RB, Cuzner ML, Kreutzberg GW, Newcombe J. Amyloid precursor protein (APP) expression in multiple sclerosis lesions. Glia 15: 141-151 (1995).
22. Mattsson N, Axelsson M, Haghighi S, Malmeström C, Wu G, Anckarsäter R, et al. Reduced cerebrospinal fluid BACE1 activity in multiple sclerosis. Mult Scler 15: 448-454 (2009).
23. Wallin AK, Blennow K, Andreasen N, Minthon L. CSF biomarkers for Alzheimeŕs disease: levels of -amyloid, tau, phosphorylated tau relate to clinical symptoms and survival. Dement Geriatr Cogn Disord 21: 131-138 (2006).
24. Anthony IC, Norrby KE, Dingwall T, Carnie FW, Millar T, Arango JC, et al. Predisposition to accelerated Alzheimer-related changes in the brains of human immunodeficiency virus negative opiate abusers. Brain 133: 3685-3698 (2010).